GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NSE:DRREDDY) » Definitions » Inventories, Raw Materials & Components

Dr Reddy's Laboratories (NSE:DRREDDY) Inventories, Raw Materials & Components : ₹26,278 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dr Reddy's Laboratories Inventories, Raw Materials & Components?

Dr Reddy's Laboratories's inventories, raw materials & components for the quarter that ended in Sep. 2024 was ₹26,278 Mil.

Dr Reddy's Laboratories's quarterly raw materials increased from Mar. 2024 (₹24,081 Mil) to Jun. 2024 (₹24,841 Mil) and increased from Jun. 2024 (₹24,841 Mil) to Sep. 2024 (₹26,278 Mil).

Dr Reddy's Laboratories's annual raw materials declined from Mar. 2022 (₹17,507 Mil) to Mar. 2023 (₹16,001 Mil) but then increased from Mar. 2023 (₹16,001 Mil) to Mar. 2024 (₹24,081 Mil).

Dr Reddy's Laboratories Inventories, Raw Materials & Components Historical Data

The historical data trend for Dr Reddy's Laboratories's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Inventories, Raw Materials & Components Chart

Dr Reddy's Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,134.00 15,574.00 17,507.00 16,001.00 24,081.00

Dr Reddy's Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20,654.00 23,123.00 24,081.00 24,841.00 26,278.00

Dr Reddy's Laboratories Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Dr Reddy's Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NSE:DRREDDY) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
BOM:543904 BOM:532321 NSE:TORNTPHARM BOM:500257 NSE:AUROPHARMA NSE:ALKEM NSE:DIVISLAB BOM:532296 BOM:524494 BOM:532331 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA VTRS HKSE:03692
Traded in Other Exchanges
RDY:USA 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Website
https://www.drreddys.com
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines